Zoetis Inc. (NYSE:ZTS) Shares Acquired by Kestra Investment Management LLC

Kestra Investment Management LLC boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 106.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,057 shares of the company’s stock after purchasing an additional 3,129 shares during the period. Kestra Investment Management LLC’s holdings in Zoetis were worth $987,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Atlantic Edge Private Wealth Management LLC lifted its stake in Zoetis by 482.8% during the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock valued at $28,000 after purchasing an additional 140 shares during the last quarter. Darwin Wealth Management LLC acquired a new stake in Zoetis during the third quarter valued at approximately $31,000. First Personal Financial Services acquired a new stake in Zoetis during the third quarter valued at approximately $33,000. Capital Performance Advisors LLP acquired a new stake in Zoetis during the third quarter valued at approximately $33,000. Finally, Dunhill Financial LLC lifted its stake in Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Zoetis

In other news, EVP Roxanne Lagano sold 326 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $171.18, for a total transaction of $55,804.68. Following the transaction, the executive vice president now owns 16,107 shares in the company, valued at $2,757,196.26. This represents a 1.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.16% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ZTS has been the subject of several research analyst reports. Stifel Nicolaus reduced their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Barclays upped their price target on shares of Zoetis from $242.00 to $244.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target for the company. Finally, Piper Sandler reduced their price target on shares of Zoetis from $210.00 to $200.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Zoetis has a consensus rating of “Buy” and an average target price of $214.90.

Zoetis Stock Down 0.7 %

Zoetis stock opened at $156.43 on Wednesday. The firm has a market cap of $70.05 billion, a PE ratio of 28.60, a P/E/G ratio of 2.71 and a beta of 0.90. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75. The firm’s 50 day moving average price is $167.70 and its two-hundred day moving average price is $178.44. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company had revenue of $2.32 billion for the quarter, compared to analyst estimates of $2.30 billion. On average, research analysts predict that Zoetis Inc. will post 6.06 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.28%. Zoetis’s dividend payout ratio (DPR) is 36.56%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.